
Novo to Build $6 Billion Plant as Obesity Drug Demand Surges
Novo Nordisk A/S will invest more than 42 billion kroner ($6 billion) to expand its manufacturing facilities as
1970-01-01 08:00

Astra Enters Obesity Drug Race With Chinese Biotech Deal
AstraZeneca Plc clinched a deal to develop a drug from the pharma industry’s hottest class of medicines, agreeing
1970-01-01 08:00

New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper
An effective and massively popular weight-loss drug has made Novo Nordisk A/S billions of dollars and turned it
1970-01-01 08:00

Eli Lilly Wins FDA Nod for Obesity Drug That Rivals Wegovy, Ozempic
Eli Lilly & Co. won US approval for its diabetes drug to treat obesity, unlocking blockbuster sales potential
1970-01-01 08:00

European Stocks On Track for Best Run Since July on Fed Optimism
European shares advanced for a fourth day, set for their longest winning streak since July, fueled by hopes
1970-01-01 08:00

Novo Nordisk’s Earnings Surge on Frenzy for Obesity Drugs
Novo Nordisk A/S sales surged in the third quarter as demand continued unabated for its obesity and diabetes
1970-01-01 08:00

When Japan Ends Negative Rate Policy, Treasuries Will Suffer
Japan’s era of negative interest rates will end in coming months, and the implications for world markets will
1970-01-01 08:00

China Weight-Loss Drug Stocks Lose Shine on ‘Misleading’ Claims
One of the few bright spots in China’s battered equity market is evaporating, with weight-loss drugs plunging after
1970-01-01 08:00

A $245 Billion Selloff Signals Less Sparkly Future for Luxury Stocks
The wealthy shoppers who fueled LVMH’s rise to Europe’s most valuable company and made its founder the world’s
1970-01-01 08:00

Novo’s Blockbuster Ozempic Now Shows Kidney Promise, Hitting Rivals
Novo Nordisk A/S said a kidney failure study of its diabetes drug Ozempic showed effectiveness surprisingly early, sending
1970-01-01 08:00

LVMH Sales Growth Slows as Global Luxury Demand Cools
LVMH’s sales growth softened in the third quarter as shoppers reined in spending on high-end Cognac and costly
1970-01-01 08:00

Ozempic Is Causing ‘Slight Pullback’ by Shoppers, Walmart Says
Walmart Inc. says it’s already seeing an impact on shopping demand from people taking the diabetes drug Ozempic,
1970-01-01 08:00